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Ever since Linus Pauling published his studies, the effects of vitamin C have been
surrounded by contradictory results. This may be because its effects depend on a
number of factors such as the redox state of the body, the dose used, and also
on the tissue metabolism. This review deals with vitamin C pharmacokinetics and its
participation in neurophysiological processes, as well as its role in the maintenance
of redox balance. The distribution and the concentration of vitamin C in the organs
depend on the ascorbate requirements of each and on the tissue distribution of
sodium-dependent vitamin C transporter 1 and 2 (SVCT1 and SVCT2). This determines
the specific distribution pattern of vitamin C in the body. Vitamin C is involved in
the physiology of the nervous system, including the support and the structure of the
neurons, the processes of differentiation, maturation, and neuronal survival; the synthesis
of catecholamine, and the modulation of neurotransmission. This antioxidant interacts
with self-recycling mechanisms, including its participation in the endogenous antioxidant
system. We conclude that the pharmacokinetic properties of ascorbate are related to the
redox state and its functions and effects in tissues.
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INTRODUCTION
Vitamin C is involved in the maintenance of body functions. However, there is a great deal of
studies that show contradictory results about its effects. From the time it was first isolated in 1928,
numerous studies have been done on its biochemical and pharmacokinetic properties, its functions
and even the role of this molecule in neurophysiology. It is important to identify the role vitamin C
has in the maintenance of oxide/reduction (redox) balance, as well as the possible effect it may have
on the treatment of chronic degenerative diseases, autoimmune diseases and cancer. The purpose
of this review is to update the current state of knowledge on vitamin C and the relevance it has in
medicine since its effects are yet to be fully understood.
Ascorbic Acid, Ascorbate, and Vitamin C
Ascorbic acid is a neutrally charged molecule which can be protonated and become ascorbate.
Depending on the pH of the medium in which it is located, ascorbic acid may lose the hydrogen
ions attached to one of its two ionizable groups located at carbons 2′ and 3′, generating ascorbate
monoanion or dianion (Tolbert et al., 1975; Markarian and Sargsyan, 2011; Du et al., 2012;
Figure 1). Ascorbic acid is a white crystalline solid soluble in water; one of its important roles lies
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FIGURE 1 | pH-dependent forms of vitamin C. At pH 7, close to plasma pH, the predominant form of vitamin C will be ascorbate monoanion, followed by ascorbic
acid and, in very low concentrations, ascorbate dianion (0.005%); in an acidic pH, the predominant form will be ascorbic acid.
in its biochemical function in redox processes. When we talk of
vitamin C, we refer to the group of ascorbic acid analogs that
can be both synthetic and natural molecules (Huh et al., 1998;
Raic´-Mlic´ et al., 2000; Yamamoto et al., 2002).
Biosynthesis
Plants and many animals have the capacity to synthesize
ascorbic acid through several biosynthesis pathways (Figure 2).
In fish, amphibians, reptiles, and bird species belonging to
older taxonomic orders the enzymes involved in vitamin C
biosynthesis are located mainly in the kidneys, while in mammals
and bird species from more recent orders these enzymes are
found mainly in the liver (Grollman and Lehninger, 1957;
Chatterjee et al., 1961). However, species such as teleost fish, some
passeriform birds, guinea pigs, and some primates like humans,
have lost the ability to synthesize ascorbic acid (Grollman and
Lehninger, 1957; Linster andVan Schaftingen, 2007). The enzyme
responsible for this deficiency is L-gulonolactone oxidase, which
is highly mutated in humans despite having the gene encoding
the protein, referred to as a pseudogene (Nishikimi and Yagi,
1991; Nishikimi et al., 1994; Valpuesta and Botella, 2004). For this
reason, these species require ascorbic acid from the diet, mainly
that synthesized by plants (Figure 2).
PHARMACOKINETICS
Absorption Mechanisms
Ascorbate is the main form of vitamin C in the human body
(Rumsey and Levine, 1998). This molecule acts as a co-substrate
for several enzymes that are important for the functioning
of the organism. Its activity as an antioxidant includes the
ability to be reversibly oxidized to ascorbyl radical and then to
dehydroascorbate (DHA; Wells and Xu, 1994).
Both forms are ingested in the diet, since ascorbate can be
oxidized in the gastrointestinal tract (GIT) by the presence of
other substances that act as oxidizing agents [e.g., Iron (F3+) and
some flavonoids] (Wilson, 2002). Ascorbate may also be oxidized
as a result of food processing, either by cooking techniques or
by improper storage techniques in the case of packaged products
(Wilson, 2002).
Sodium-Dependent Vitamin C Transporters
(SVCTs)
Two sodium-dependent vitamin C transporters have been
described, SVCT1 and SVCT2; both are glycoproteins that
transport ascorbate into the cell. SVCT1 is encoded by a gene
that belongs to the family of solute carriers, group 23A, member
1 (SLC23A1) of 1797 bp, while the SLC23A2 gene of 1952 bp
encodes SVCT2 (Daruwala et al., 1999). In addition, it has been
documented that SVCT1 transports ascorbate nine times faster
(Steiling et al., 2007) than SVCT2, while the latter has a higher
affinity for ascorbate, with an apparent Km of 21.3 uM for SVCT2
and of 252.0 uM for SVCT1 (Daruwala et al., 1999; Figure 3).
The properties of these two transporters are likely to be the
explanation of their tissue distribution. SVCT1 is found mostly
in epithelial tissues (e.g., small intestine and proximal tubule
of the nephron), where the transport of ascorbate is greater
than that required by the cells. On the other hand, SVCT2 is
found mainly in brain, skeletal muscle, placenta, and eye, where
the contribution of ascorbate is tightly controlled to maintain
adequate tissue concentrations (Wilson, 2005; Figure 3.1). The
transport mediated by these glycoproteins is a secondary
active, saturable Na+-dependent transport (Tsukaguchi et al.,
1999).
Glucose Transporters (GLUTs)
There have been described 14 GLUT proteins belonging to
the family of solute carriers, group 2A (SLC2A; Mueckler and
Thorens, 2013). Within this group, only GLUT1 and GLUT3,
and to a lesser extent GLUT4, have been found to have the
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FIGURE 2 | Vitamin C biosynthesis. The initial metabolite of both pathways is glucose, which through a sequence of reactions involving an energy expenditure by
the cell, synthesizes L-ascorbic acid. 1, Glucose-6-phosphate isomerase; 2, Mannose-6-phosphate isomerase; 3, Phosphomannomutase; 4, GDPD-mannose
pyrophosphorylase; 5, GDP-D-mannose-3,5-epimerase; 6, Phosphodiesterase; 7, Sugar phosphatase; 8, L-galactose dehydrogenase; 1′, Phosphoglucomutase; 2′,
UDP-glucose pyrophosphorylase; 3′, UDP-glucose dehydrogenase; 4′, Glucuronate-1-phosphate uridylyltransferase and Glucurono kinase; 5′, Glucuronate
reductase; 6′, Aldono-lactonase.
FIGURE 3 | Influx and efflux mechanisms. (3.1) The type of SVCT transporter depends on the characteristics and requirements in each cell, SVCT2 being more
frequent in tissues that require a constant supply of ascorbate, even under vitamin C deficiency conditions, while SVCT1 is more frequent in cells responsible for tissue
distribution of ascorbate. (3.2) Ascorbate transportation into the enterocyte occurs through SVCT1, coupled to a Na+/K+ATPase. (3.3) Under conditions of restricted
ascorbic acid intake, the supply of ascorbate to the cell is carried out through the SVCT2 located in the basolateral membrane, which is also coupled to a
Na+/K+ATPase. (3.4) DHA is transported into the enterocyte via GLUT transporters. (3.5) Within the enterocyte, DHA is reduced to ascorbate, then exits the cell and
spreads to the capillaries through the extracellular space.
capacity to transport DHA (Li and Schellhorn, 2007). However,
the ability of GLUT8 and GLUT2 to transport DHA into rat
enterocytes has been shown (Corpe et al., 2013); this is important
because GLUT8 and GLUT2 are also present in the human
small intestine (Doege et al., 2000; Mueckler and Thorens,
2013).
Each of these transporters has its own characteristics and
a specific tissue distribution. The GLUT1 isoform is widely
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expressed in the body; its presence in endothelial cells of
the blood-brain barrier may contribute to the maintenance of
concentration of ascorbate in the brain (Li and Schellhorn, 2007).
GLUT3 is a high affinity transporter (low Km) that initially
was thought to be only present in neuronal cells, but now has
been found in sperm, embryos, and leukocytes (Mueckler, 1994;
Simpson et al., 2008). GLUT4 is expressed mainly in adipocytes
and in skeletal and cardiac muscles; an important feature of this
transporter is that it is found mostly within intracellular vesicles
which attach to the plasma membrane in response to insulin
(Mueckler, 1994). GLUT 2 has the peculiarity of being a low
affinity transporter (Km ∼ 17mM); it is found in hepatocytes,
enterocytes of the small intestine, proximal tubular cells, and β-
pancreatic cells (Mueckler, 1994). GLUT8 is found in skeletal
muscle, heart, small intestine, brain, and testis; its expression
in testis can be suppressed by estrogens (Doege et al., 2000)
Therefore, DHA transport is performed by a facilitated, saturable
diffusion mechanism mediated by some GLUT transporters,
which, unlike the transport of ascorbate, is Na+ independent.
Mechanisms of Entry into Enterocytes
Both ascorbate and DHA can enter enterocytes via SVCT
and GLUT transporters, respectively. The absorption pattern
of ascorbate is opposite to that of glucose as ascorbate is
better absorbed in the most distal segments (ileum) of the
small intestine and, in smaller quantities, in the most proximal
segments (duodenum). For its part, DHA is better absorbed in
the jejunum while very little is absorbed in the distal segments of
the ileum (Malo and Wilson, 2000).
One study showed that both SVCT1 and SVCT2 are expressed
by enterocytes, but their distribution in the plasma membrane
is polarized, as SVCT1 is found in the apical side of cells
(Figure 3.2) and SVCT2 is present in the basolateral membrane
(Boyer et al., 2005; Figure 3.3).
Part of the DHA absorbed corresponds to ascorbate oxidized
in the lumen of the gastrointestinal tract (Wilson, 2002;
Figure 3.4). It is yet to be defined which GLUT transporters are
responsible for transporting DHA into the enterocyte. Although
Corpe et al. proposed that GLUT2 and GLUT8 might be the
transporters (Corpe et al., 2013), their study was performed using
rats; additionally, other studies hold contradictory views. Some
even point out that GLUT2 is not a DHA transporter (Cura and
Carruthers, 2012), but others show that it is (Mardones et al.,
2011).
Efflux Mechanisms
Although some hypotheses have been proposed, it is still
unknown how ascorbate exits the cells. One of the hypotheses
holds that epithelial enterocytes and renal proximal tubule cells
swell when transporting some metabolites (Wilson, 2002, 2005).
This process could activate volume sensitive anion channels
(VSAC) located in the basolateral membrane which would allow
the exit of ascorbate from inside the cell. It must be said that
even though the effect has been observed, the protein has not
been identified in enterocytes yet (Wilson, 2002, 2005; Corti
et al., 2010; Figure 3.5). The VSAC are a family of membrane
proteins that mediate the passive transport of organic anions
in response to changes in intracellular osmolarity (Jackson and
Strange, 1993; Strange and Jackson, 1995). This mechanism has
been demonstrated in cultured astrocytes (Siushansian et al.,
1996) and it is very likely to be present in enterocytes as well.
Another mechanism that has been proposed as transporter is
an ascorbate-glutamate hetero-exchange (Grûnewald and Fillenz,
1984); however, some researchers believe its existence is unlikely
and attribute the glutamate effect to the fact that glutamate favors
the entry of Na+/Cl- activating N-methyl-D-aspartate (NMDA)
and non-NMDA receptors, glutamate transporters and voltage-
gated sodium channels (Vogler et al., 2013), causing the cell to
swell and to activate VSAC (Corti et al., 2010). Ascorbate release,
mediated by an exocytosis process (Von Zastrow et al., 1984) or
by its passage through gap junctions (Wilson, 2005) has also been
proposed as transporter. As for DHA, it is reduced to ascorbate
inside the enterocyte by complex recycling mechanisms; then it
exits the cell and goes into the extracellular space where it reaches
the bloodstream through fenestrated capillaries that supply the
mucosa of the small intestine (Wilson, 2002, 2005).
Tissue Distribution
The organs with the highest concentration of ascorbate are
the adrenal glands (550mg/kg), the brain (140mg/kg), the
liver (125mg/kg), and in terms of size, the skeletal muscle
with a concentration of 35mg/kg (Richelle et al., 2006). The
function performed by ascorbate in each cell of these organs will
determine the type of transporter that is best suited for their local
requirements. Regarding the central nervous system (CNS), the
ascorbate located in the cerebrospinal fluid diffuses freely into
the extracellular space of neurons and glia, where it is captured
by both cell types via SVCT2 (except for astrocytes; García Mde
et al., 2005; Savini et al., 2008; Gess et al., 2010). SVCT2 is the
main transporter in the adrenal glands, (Savini et al., 2008); it
maintains high concentrations of ascorbate in the chromaffin
cells of the adrenal medulla, which are essential for the synthesis
of catecholamines. SVCT1 is the most abundant transporter in
the liver although SVCT2 is also expressed. A study carried out
byMichels, Joisher andHagen showed a decrease in the ascorbate
uptake in rat hepatocytes due to a lower expression of the mRNA
of SVCT1 associated with age (Michels et al., 2003).
In order for ascorbate to be able to reach tissues, it
must go through the endothelial barrier of each tissue.
One report demonstrated that ascorbate transport takes place
primarily through a paracellular pathway (except in CNS) since
transcellular transport is not correlated with the ascorbate
transferred across the endothelium. Thus, ascorbate transport
will depend on the narrowness of the space that exists between
endothelial cells. This suggests that the process may be influenced
by the rigidity conferred by ascorbate to the cytoskeleton of the
cells forming the barrier (May et al., 2009).
VITAMIN C AND CNS
Ascorbate functions in the nervous system can be divided as
follows: firstly, the interaction of ascorbate with the blood-
brain barrier as well as its medical implications; secondly, its
effects on the process of neuronal differentiation, maturation and
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survival; thirdly, its effect on modulating neurotransmission and
its participation in catecholamine synthesis. Finally, it has an
antioxidant effect and it also plays a role in the learning and
memory process as well as in the structure and support of the
nervous system.
Blood-Brain Barrier
The blood-brain barrier is formed by three cells: the endothelium
of the microvasculature of the brain, pericytes, and astrocytes.
It has been proposed that astrocytes may induce the formation
of the tight junctions between endothelial cells and influence
the characteristic phenotype of the transporters of the blood-
brain barrier (e.g., GLUT1 and amino acid transporter L1;
Abbott, 2002). For their part, pericytes appear to be involved
in both maintaining the structural integrity of the vessel
wall and regulating angiogenesis; they also seem to have a
neuroimmunological effect due to their ability to phagocytize
(Ballabh et al., 2004).
The main function of the blood-brain barrier is to maintain
the internal microenvironment of the CNS, mediating the
selective transport of nutrients, ions, waste products, drugs, and
other substances (Abbott et al., 2006). Although ascorbate can
penetrate into the CNS through the choroid plexus, it cannot
cross through the blood-brain barrier because the tight junctions
of the endothelium do not allow ascorbate transport through the
paracellular pathway (Harrison and May, 2009). What is more,
SVCT2 is not expressed in these cells (Qiao and May, 2009).
Even though DHA can cross the blood-brain barrier through
GLUT1 (Agus et al., 1997), it is not the main pathway through
which ascorbate reaches the CNS; nevertheless it could be an
important route from a therapeutic point of view. Huang et al.
administered different doses of DHA intravenously before and
after the induction of a stroke in mice. They found that DHA
had a neuroprotective effect directly proportional to the dose
administered. The protective effect was significant whether DHA
was injected before or after the stroke (Huang et al., 2001).
Ascorbate distribution in the brain is not uniform. The
amygdala, the hippocampus and the hypothalamus are the
brain regions with the highest concentration of vitamin C, but
even in these structures the distribution is not homogeneous
(Mefford et al., 1981). For example, the medial nucleus has a
greater concentration of ascorbate in the hypothalamus than in
either the preoptic nucleus or the posterior nucleus (Mefford
et al., 1981). The substantia nigra is the brain region with the
lowest concentration of ascorbate (Grümewald, 1993), which
could be considered a susceptibility factor for oxidative stress
if we consider that the synthesis of dopamine is pro-oxidant
and needs ascorbate. Therefore, the requirements of ascorbate
that dopaminergic neurons need may be the cause of the low
ascorbate levels found in this brain structure.
Vitamin C and Neuronal Differentiation,
Maturation, and Survival
The effect of ascorbate on the differentiation of embryonic stem
cells into neurons in vitro is associated with an increase in
the expression of genes involved in this process (Harrison and
May, 2009). Lee et al. found that cells treated with ascorbate
significantly increased the expression of NeuroD, Notch, BMP2,
and BMP7, genes associated with the differentiation of neuronal
and astrocytic cells. The same study demonstrated that vitamin
E and glutathione do not have the same effect as ascorbate on
neuronal cell differentiation so that the mechanism involved
might not be directly related with its antioxidant effect (Lee
et al., 2003). An increase in neurite formation in neurons in vitro
due to the potentiating effect of 2-glucoside-L-ascorbic acid
(ascorbate analog) on the nerve growth factor (NGF) has also
been shown. This is an effect that the authors also attributed to a
different mechanism given its antioxidant properties (Haramoto
et al., 2008). An increase in the expression of brain-derived
neurotrophic factor (BDNF) associated to the presence of
ascorbate has also been observed in cell culture. BDNF activates
the Ras-MAP kinase pathway, which contributes to cell survival
by enhancing the expression of the enzymes of the endogenous
antioxidant system [superoxide dismutase (SOD), glutathione
peroxidase and glutathione reductase] (Grant et al., 2005).
Vitamin C, Catecholamine Biosynthesis
and Modulation of Neurotransmission
As it was said before, ascorbate plays an important role in
the synthesis of catecholamines, particularly dopamine and
norepinephrine. Seitz et al. proposed that the modulatory effect
of ascorbate can be divided into short and a long term.
The short term refers to its participation as a co-substrate
for tyrosine hydroxylase and dopamine-β-hydroxylase; and the
long term effect, to the increased gene expression of tyrosine
hydroxylase, probably through a mechanism that involves an
increase in intracellular cAMP; however, the latter is still just
a hypothesis (Seitz et al., 1998). Studies in ascorbate-deficient
guinea pigs showed that the subjects had high dopamine and low
norepinephrine levels due to alterations in the catalysis mediated
by dopamine-β-hydroxylase; the levels were normalized even
with low ascorbate concentration in the brain (Harrison andMay,
2009). There are also reports which state that ascorbate promotes
and maintains the differentiation of dopaminergic cells derived
from midbrain neural precursors in vitro (Yan et al., 2001). Yu
et al. carried out a study to identify the genes involved in the
differentiation of these cells, and they found the upregulation of
up to 92 genes and the downregulation of 118 genes, varying
according to the stage of cell differentiation (Yu et al., 2004).
An increase in the susceptibility to excitotoxicity mediated by
the NMDA glutamate receptor in mice with SVCT2 deficiency
has also been shown (Qiu et al., 2007). This mechanism can
be explained either by an antioxidant effect of ascorbate on
reactive oxygen species (ROS) generated by the activation of
the receptor or by the interaction of ascorbate with a redox
modulation site at the NMDA receptor level (Majewska et al.,
1990). Other authors have described the effect of ascorbate
as an inductor of the liberation of gonadotropins (luteinizing
hormone and follicle-stimulating hormone) (Karanth et al.,
2001). What they propose is that ascorbate released by the
vesicles of the gonadotrope cells is recaptured by SVCT2 via
an unknown mechanism and facilitates the entry of Ca2+
into the cell, which interacts with calmodulin and induces an
increase in the activity of neuronal nitric oxide synthase (nNOS).
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Nitric oxide (NO) activates guanylate cyclase increasing the
amount of cGMP. Finally, cGMP activates the protein kinase C
(PKC), leading to exocytosis of gonadotropine (Karanth et al.,
2001).
Vitamin C, Learning, and Memory
Parle and Dhingra injected doses of 60 and 120mg/kg of ascorbic
acid intraperitoneally to mice with drug-induced amnesia via
the administration of diazepam and scopolamine and to mice
that acquired amnesia naturally with age (Parle and Dhingra,
2003). Using the elevated plus maze and the passive avoidance
test, the authors concluded that ascorbic acid improved learning
and memory in old mice and protected the mice in the
group that received the drugs (Parle and Dhingra, 2003).
Similarly, other studies have shown that the combination of
vitamin C and vitamin E can have beneficial effects preventing
memory alterations (Delwing et al., 2006; Hasanein and Shahidi,
2010). However, it has not been possible to demonstrate the
reproducibility of these results nor their efficacy in human
studies focused on the prevention and treatment of dementia
and Alzheimer’s disease (Boothby and Doering, 2005; Fillenbaum
et al., 2005).
Studies conducted in our laboratory have demonstrated that
vitamin C effects on learning and memory are dependent on
the redox balance state. When we gave a low dose of vitamin C
(50mg/kg) to healthy rats, their retention latency in the passive
avoidance test decreased. Then, when we exposed a group of
rats to an acute dose of ozone (0.7 ppm) without vitamin C, the
retention latency in the passive avoidance test also decreased.
Nevertheless, when we gave the same dose of vitamin C to rats
exposed to ozone, the retention latency was similar to that of
the control, demonstrating a protective effect of the vitamin
(Graphic 1). Subsequently, we compared these results with the
lipid peroxidation levels in the hippocampus and we observed
a relationship between the oxidative damage and the deficit
in the passive avoidance test (Graphic 2). This showed a pro-
oxidant effect of low dose vitamin C in a redox equilibrium and
an antioxidant effect at any doses in an oxidative stress state
(Dorado-Marínez et al., 1998).
Vitamin C and CNS Structure
Ascorbate has an important role in the synthesis of collagen and
elastin, components of the blood vessels that supply the neural
tissue and the basal lamina (Harrison and May, 2009); moreover,
the role of ascorbate as an inductor of myelination mediated
by Schwann cells has also been demonstrated. Fernandez-Valle
et al. observed that adding ascorbate to cultures of Schwann
cells with ganglion neurons favored the production of the
basal lamina, essential for the induction of myelination, and
seemed to induce protein zero mRNA (PZM), which is a major
component of myelin; however, the mRNA expression of this
protein was not exclusive of the ascorbate culture (Fernández-
Valle et al., 1993). It has also been shown that myelination
occurs in the presence or absence of ascorbic acid and that the
differences under these culture conditions were dependent on
laminin (Podratz et al., 2001). Other authors have described
that p38, a member of the family of MAP kinases, plays an
Graphic 1 | Effects of different doses of vitamin C on memory in redox
balance and in oxidative stress. The retention latency was significantly
decreased in the short term memory (STM) and in the long term memory (LTM)
in the group that receive 0.7 ppm of ozone (O3) and in the group that receive
50mg/kg of vitamin C (C50). Meanwhile, at any other doses greater than
50mg/kg the retention latency were similar to the one of the control group.
When any doses of vitamin C were added to the group exposed to ozone, the
retention latency in STM and LTM was similar to that of the control group.
Graphic 2 | Effects of different doses of vitamin C on lipid peroxidation
levels in hippocampus in redox balance and in oxidative stress. The
lipid peroxidation levels mainly increased in the group exposed to ozone (O3)
and in the group that receive 50mg/kg of vitamin C (C50). At any doses of
vitamin C greater than 50mg/kg the effect on lipid peroxidation levels was not
as evident as in the C50 and O3 groups. In the groups that receive vitamin C
and were exposed to ozone, vitamin C exerted an antioxidant effect (O3 +
C50 and O3 + C100), except in the O3 + C200 group.
important role during the early stages of myelination induced
by both ascorbate and laminin (Fragoso et al., 2003). Therefore,
the main effect of ascorbate on myelination is probably due
to the maintenance of the structural integrity of the basal
lamina.
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Antioxidant Role of Vitamin C in CNS
The brain consumes 20% of the total body oxygen and has
a high metabolic rate, making it a readily oxidizable tissue
(Erecin´ska and Silver, 2001). These conditions justify the
importance of the presence of antioxidants in the brain, which
are needed to maintain the redox balance. The distribution
of these antioxidants is not uniform since neurons can
reach intracellular ascorbate concentrations of 10mM and a
glutathione concentration of 2.5mM as opposed to what happens
in glia where the concentration of ascorbate is 2.5mM and the
one of glutathione is 3.8mM (Rice and Russo-Mena, 1997). The
uneven distribution of ascorbate is due to the fact that SVCT2 is
preferentially expressed in neurons; while in astrocytes ascorbate
concentrates through the intracellular reduction of DHA which
enters the cell via GLUT1. The physiological significance of
this unequal distribution is the supply of ascorbate to the
neuron. An increase in the expression of mRNA related to the
translation of SVCT2 in both neurons and astrocytes has been
proven in rats with induced cerebral ischemia, probably as a
cellular protective mechanism against oxidative stress induced
by ischemia (Berger et al., 2003). Some researchers have studied
the interaction of ascorbate with other antioxidants such as α-
tocopherol (Niki et al., 1995) and gluthation (Puskas et al., 2000)
as well as the possible therapeutic applications of this interaction,
e.g., in the prevention of Alzheimer’s disease (Morris et al.,
1998).
ROLE IN REDOX BALANCE
There is a constant balance between oxidants and antioxidants
in the body that helps to maintain “redox homeostasis.” This
means that when there is an increase the production of
ROS, the body’s response will be to increase of the activity
of endogenous antioxidant systems through a mechanism of
redox signaling (Valko et al., 2007). In addition, antioxidants
can be obtained from exogenous sources; along with the
endogenous antioxidant system, these exogenous antioxidants
play an important role in maintaining the redox balance. The
endogenous antioxidant systems comprise antioxidant enzymes
(e.g., catalase, superoxide dismutase, and glutathione peroxidase)
and antioxidant molecules (e.g., glutathione and thioredoxin;
Dröge, 2002). Vitamin C, vitamin E and flavonoids are among
the exogenous antioxidant molecules ingested in the diet.
There are also molecules that function as metal chelators (e.g.,
lactoferrin and transferrin), avoiding the production of the
hydroxyl radical through the Fenton and Haber-Weiss reaction
(Valko et al., 2007). An increase in reactive oxygen and nitrogen
species that exceeds the ability of the antioxidant system to
counteract the increase of ROS leads to an “oxidative stress
state.”
The antioxidant effect of ascorbate is due to its ability
to donate electrons from both the second and third carbon
(Padayatty et al., 2003; Mahfouz and Kummerow, 2004). It has
also been demonstrated that ascorbate is more effective than
thiols, α-tocopherol, and urate to prevent lipid peroxidation in
plasma. Research reported that the higher the concentration of
ascorbate in blood is, the greater the time it is required to initiate
lipid peroxidation with no pro-oxidant effects, even in ascorbate
serum concentrations of 5mM achievable only parenterally (Frei
et al., 1989).
Recycling Mechanisms
To prevent the loss of intracellular concentrations of ascorbate
and other antioxidant molecules such as glutathione, cells have
recyclingmechanisms formed by exogenous antioxidants and the
endogenous antioxidant system.
The ascorbyl radical is a relatively stable molecule with an
average life of 10–5 s (Buettner, 1993; Padayatty et al., 2003).
Its low reactivity is due to the ability of the unpaired electron
to resonate between carbons 1′ and 3′ (May, 1999) without
interacting with O2 (Bielski and Richter, 1975). Two ascorbyl
radicals can react with each other through a dismutation reaction
in which one molecule is reduced to ascorbate and the other is
oxidized to DHA. Another mechanism involved in the reduction
of the ascorbyl radical is the NADH-dependent system mediated
by the ascorbyl free radical reductase (AFR reductase) located
in the cell membrane (May et al., 2001). Two types of AFR
reductases have been described, those which are transmembrane
and those found in the inner membrane. Both enzymes seem to
be at a convenient location since the ascorbyl radical is formed in
the plasma membrane by the reduction of α-tocopherol; thereby
counteracting the radicals generated in the intracellular side (May
et al., 2001). The α-tocopherol is a lipid antioxidant located near
the surface of membranes and lipoproteins where it interacts
with ascorbate, which is in the liquid phase of the interface (Niki
et al., 1995). By donating an electron, α-tocopherol is oxidized
and converted into α-tocopheryl radical, returned to its reduced
form by the oxidation of ascorbate interface (Niki et al., 1995).
Thioredoxins are cellular proteins that catalyze the reduction
of disulphides in different enzymes (e.g., ribonucleotide
reductase) through the transfer of an electron from their thiol
group (Arnér and Holmgren, 2000). Thioredoxin reductase is
the enzyme responsible for keeping thioredoxin in its reduced
form; however, there are reports of the ability of this enzyme
to recycle DHA and ascorbyl radical into ascorbate by an
NADPH-dependent process in cytosol (Mustacich and Powis,
2000). The glutathione and dihydrolipoic acid are capable of
reducing DHA to ascorbate, besides dihydrolipoic acid can also
reduce the ascorbyl radical (Kagan et al., 1992; Valko et al.,
2007). The relevance of studying these recycling mechanisms is
that many of them can be altered in a chronic oxidative stress
state, making it more difficult to maintain normal ascorbate
concentrations; thereby increasing the requirements for vitamin
C in some subjects.
Pro-oxidant Effect of Vitamin C
The pro-oxidant ability of ascorbate is associated with the
presence of free dissolvedmetals. A prooxidant effect of ascorbate
dependent on the time at which it was administered to rats
has been demonstrated (Kang et al., 1998). After injecting
paraquat-dichloride intraperitoneally, the researchers recorded
an increase in ethane exhalation (oxidative stress marker) and
observed lung tissue damage under the microscope. When
10mg/kg of ascorbate were administered intravenously prior
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to the injection of paraquat dichloride, a protective effect was
observed; however, when ascorbate was administered 1 h after the
paraquat dichloride injection, both ethane and tissue damage had
increased. The explanation proposed by that study was that the
interaction of ascorbate with freemetals caused the tissue damage
(Kang et al., 1998).
Another study reported an increase in 8-oxoadenine levels
(DNA oxidative damage marker) and, paradoxically, a decrease
in 8-oxoguanosine levels from basal measurements when
supplementing 30 healthy volunteers with 500 mg/day of vitamin
C for 6 weeks, compared to the results observed with the
placebo group (Podmore et al., 1998). When working with six
healthy volunteers, other authors found that the intravenous
administration of 750 or 7500mg of vitamin C did not increase
the levels of lipid peroxides nor 8-oxoguanosine (Mühlhöfer
et al., 2004). Therefore, some have criticized the results published
by Podmore et al. suggesting possible methodological errors
(Levine et al., 1998).
Chen et al. demonstrated a susceptibility effect of different
types of cancer cells at pharmacological doses (0.3–20mM) of
vitamin C in vitro. The mechanism was attributed to the ability of
ascorbate to produce H2O2 in the extracellular space only when
the ascorbyl radical levels were >100 nM (Chen et al., 2007).
They also found that the production of H2O2 depended on the
presence of redox-active metal centers of proteins (Chen et al.,
2005, 2008), which led them to study this effect in amousemodel.
They demonstrated a significant decrease in tumor cell growth
and tumor weight due to a pro-drug effect of vitamin C (Chen
et al., 2008).
A process of ascorbate autoxidation has been proposed
when ascorbate is found in its dianionic form. In their review,
Du, Cullen and Buettner described that the concentration of
dianionic ascorbate increases by a factor of 10 for every pH
unit increase (Du et al., 2012). An increased susceptibility to
auto-oxidation of dianionic ascorbate has been shown as well
(Williams and Yandell, 1982); however, this process does not
occur under physiological pH (Buettner, 1988). The possible
effect of dianionic ascorbate under pathological conditions with
altered pH is yet to be determined.
CLINICAL PERSPECTIVE
Given the effect of vitamin C on normal physiology, it
is apparent that it plays a role in the maintenance of
homeostasis. Nevertheless, it has not been possible to unify
the criteria for its clinical use as previous studies have not
taken into account the variability of its antioxidant effect,
which depends on the redox state of the patient, the dose, and
the right route of administration to achieve pharmacological
concentrations.
We consider it necessary to continue the study of the
therapeutic effects of vitamin C on neurodegenerative diseases,
chronic inflammatory diseases, and cancer using vitamin C as
a support for patients to decrease the oxidative stress caused by
pathological entities.
CONCLUSIONS
The pharmacokinetic properties of ascorbate are intimately
related with the functions it performs in tissues since its
distribution and concentration in the different organs of the
body depend on their requirements of vitamin C. In addition,
there exists a specific distribution pattern of ascorbate in each
organ which, in brain regions as the substantia nigra, is yet to
be fully explained. This region has the lowest levels of vitamin
C in the brain, a major topic due to the relationship that
has been established between oxidative stress and Parkinson’s
disease.
In addition, the distinction between physiological and
pharmacological doses of vitamin C, determined by the route of
absorption as well as by the pro-oxidant and antioxidant effect of
different doses of vitamin C dependent of the redox balance of the
individual, allows us to understand why some previous studies
have failed to demonstrate the health benefits of vitamin C.
Finally, the role of vitamin C in health is related to the
maintenance of the internal microenvironment determined by
the redox balance, proven to be altered in diseases such as
obesity, cancer, neurodegenerative diseases, hypertension and
autoimmune diseases. This role should be the focus of future
research using vitamin C as an adjunct in patient treatment.
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